Alx Oncology Holdings Inc
(ALXO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,442 | 19,302 | 20,614 | 17,567 | 16,102 |
| Marketable Securities | 37,184 | 60,012 | 77,217 | 110,190 | 132,472 |
| TOTAL | $66,516 | $85,257 | $102,532 | $134,352 | $155,895 |
| Non-Current Assets | |||||
| PPE Net | 1,351 | 1,497 | 2,703 | 2,905 | 3,112 |
| Investments And Advances | 5,838 | 4,232 | 9,161 | 3,524 | 14,036 |
| Other Non-Current Assets | 9,018 | 4,334 | 6,504 | 6,994 | 12,672 |
| TOTAL | $16,207 | $10,063 | $18,368 | $13,423 | $29,820 |
| Total Assets | $82,723 | $95,320 | $120,900 | $147,775 | $185,715 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,348 | 3,043 | 1,739 | 435 | N/A |
| Accounts payable and accrued liabilities | 6,583 | 4,942 | 3,985 | 4,646 | 7,954 |
| Accrued Expenses | 16,791 | 10,863 | 13,018 | 13,419 | 24,386 |
| TOTAL | $27,722 | $18,848 | $18,742 | $18,500 | $32,340 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,764 | 6,997 | 8,232 | 9,469 | 9,835 |
| Other Non-Current Liabilities | 4,437 | 5,060 | 5,631 | 6,188 | 6,733 |
| TOTAL | $10,201 | $12,057 | $13,863 | $15,657 | $16,568 |
| Total Liabilities | $37,923 | $30,905 | $32,605 | $34,157 | $48,908 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,218 | 53,551 | 53,444 | 53,384 | 52,743 |
| Common Shares | 54 | 54 | 53 | 53 | 53 |
| Retained earnings | -699,969 | -677,825 | -651,876 | -621,122 | -591,959 |
| Other shareholders' equity | 43 | 36 | 118 | 275 | 563 |
| TOTAL | $44,800 | $64,415 | $88,295 | $113,618 | $136,807 |
| Total Liabilities And Equity | $82,723 | $95,320 | $120,900 | $147,775 | $185,715 |